Carregant...
Asthma and COVID-19: In Defense of Evidence-Based SABA
There have recently been major objections to the use of short-acting beta-agonist (SABA) in episodic acute asthma culminating in a call for replacing SABA with combination of inhaled corticosteroids and long-acting beta-agonists despite little evidence supporting this point of view. It is regrettabl...
Guardat en:
| Publicat a: | J Asthma Allergy |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7575826/ https://ncbi.nlm.nih.gov/pubmed/33116658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S279061 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|